Lloyd N. Friedman, M.D.

Clinical Professor of Medicine
Pulmonary & Critical Care Medicine

Clinical Interests

• Tuberculosis
• Critical Care

Research Interests

Dr. Lloyd Friedman recently published the results of a multicenter trial investigating the incidence of reversion of latent tuberculosis infection through the use of skin tests and interferon gamma release assays. He has been following a cohort of welfare patients in New York to assess the incidence of tuberculosis, AIDS, and death. His major focus currently is an experimental project on the association of a tuberculosis and asthma. His critical care efforts include participation as a study site principal investigator in a recently reported study on the use of drotrecogin alpha (activated) in early sepsis. He also has an interest in the improvement of medical care through the use of electronic medical records.

Education:	Medical School: Yale University School of Medicine
Training:	Residency: Oregon Health Sciences University, Internal Medicine Fellowship: Yale University School of Medicine, Pulmonary & Critical Care Medicine

Selected Publications

• Friedman LN, Sullivan GM, Bevilaqua RP, Loscos R. Tuberculosis screening in alcoholics and addicts. Am Rev Respir Dis 1987; 136:1188-1192.
• Friedman LN, Filderman AE, D'Aquila TG, Reynolds, HY. ELISA analysis of BACTECR bottles for the earlier diagnosis of tuberculosis. Am Rev Respir Dis 1989; 140:668-671.
• Friedman LN, Williams MT, Singh TP, Frieden TR. Tuberculosis, AIDS, and death among substance abusers on welfare in New York City. N Engl J Med 1996; 334:828-833.
• O’Connor PG, Shi JM, Henry S, Durante AJ, Friedman L, Selwyn PA. Tuberculosis chemoprophylaxis using a liquid isoniazid-methadone admixture for drug users in methadone maintenance. Addiction 1999; 94:1071-1075.
• Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O'Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167:603-62.
• Friedman LN, Nash ER, Bryant J, Henry S, Shi J, D’Amato J, Khaled GH, Russi MB, O’Connor PG, Edberg SC, Pisani, MA, Cain HC, Tanoue L, Weissman DN. High rate of negative tuberculin and QuantiFERON® tests in individuals with histories of past-positive skin tests. Infect Control Hosp Epidemiol 2006; 27:436-41.
• Friedman LN. Mycobacterium tuberculosis. In: Bone R, Dantzker D, George R, Matthay R, Reynolds H, editors. Pulmonary and Critical Care Medicine. Chicago: Mosby-Year Book, 1992. Revised, 1994.
• Friedman LN, editor. Tuberculosis: Current Concepts and Treatment. 2nd ed. Boca Raton: CRC Press, Inc., 2000.
• Friedman LN, Halpern NA, Fackler JC. Implementing an electronic medical record. Crit Care Clin 2007; 23:347-381.

Contact

Campus Address
Department of Internal Medicine
Pulmonary and Critical Care Medicine
P.O. Box 208057
New Haven, CT 06520-8057

Office Phone
203-785-4162